Immunosuppressive therapies for alopecia areata during COVID‐19: A cross‐sectional survey study

MLA

Maryanne M. Senna, et al. “Immunosuppressive Therapies for Alopecia Areata during COVID‐19: A Cross‐sectional Survey Study.” Dermatologic Therapy, Jan. 2021. EBSCOhost, https://doi.org/10.1111/dth.14762.

APA

Maryanne M. Senna, Abby Ellison, James T. Pathoulas, Chloe J. Walker, Isabel Pupo Wiss, Natasha Atanaskova Mesinkovska, & Kelly E. Flanagan. (2021). Immunosuppressive therapies for alopecia areata during COVID‐19: A cross‐sectional survey study. Dermatologic Therapy. https://doi.org/10.1111/dth.14762

Chicago

Maryanne M. Senna, Abby Ellison, James T. Pathoulas, Chloe J. Walker, Isabel Pupo Wiss, Natasha Atanaskova Mesinkovska, and Kelly E. Flanagan. 2021. “Immunosuppressive Therapies for Alopecia Areata during COVID‐19: A Cross‐sectional Survey Study.” Dermatologic Therapy, January. doi:10.1111/dth.14762.